CRISPR patent results : Nature Reviews Microbiology : Nature Research

The CRISPR–Cas9 gene-editing technology was developed from prokaryotic defence systems and has been widely adopted for genome editing in eukaryotes. A controversial battle has been waging in the United States between the Broad Institute in Cambridge, Massachusetts, and the University of California, Berkeley, in regard to who owns the intellectual…

Read the full article at the Original Source..

Back to Top